跳至主要内容
临床试验/IRCT20190706044111N35
IRCT20190706044111N35招募中Unknown

Bioequivalence study of PuricCidal® (ciprofloxacin) 750mg tablet of Kharazmi Pharm. Co., IRAN in comparison of Sandoz Ciprofloxacin 750mg tablet in 24 healthy adult subjects under fasting condition

Kharazmi Pharm. Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Aged between 18 - 50 years
  • - Body weight between 50 – 100 kg
  • - Having good health on the basis of medical history and physical & clinical examiation
  • - Understand the procedures and give written informed consent

排除标准

  • Subject had undergone surgery of the gastro-intestinal tract
  • Subject had donated a unit of blood or participated in another clinical trial, within the last two months before the first treatment.
  • Subject had a history of drug or alcohol abuse.
  • Subject who smokes more than 10 cigarettes per day.
  • Subject had used any prescription medication within 14 days, or any non-prescription medication within 7 days, before the first treatment.

研究者

发起方
Kharazmi Pharm. Co.

相似试验